Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.75 CNY 0.94%
Market Cap: 4.7B CNY
Have any thoughts about
Hunan Fangsheng Pharmaceutical Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Hunan Fangsheng Pharmaceutical Co Ltd

Current Assets 1B
Cash & Short-Term Investments 197.3m
Receivables 336.1m
Other Current Assets 496.5m
Non-Current Assets 2.2B
Long-Term Investments 257.8m
PP&E 1.1B
Intangibles 533.2m
Other Non-Current Assets 256.6m
Current Liabilities 1.4B
Accounts Payable 140.6m
Accrued Liabilities 42.4m
Short-Term Debt 649.2m
Other Current Liabilities 555.5m
Non-Current Liabilities 327.9m
Long-Term Debt 148.2m
Other Non-Current Liabilities 179.7m

Balance Sheet
Hunan Fangsheng Pharmaceutical Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
497
533
363
139
317
152
315
257
383
182
Cash
0
0
0
0
0
1
0
257
383
182
Cash Equivalents
497
533
363
139
317
151
315
0
0
0
Short-Term Investments
0
0
0
0
0
30
0
15
40
20
Total Receivables
32
44
65
168
169
214
235
306
379
257
Accounts Receivables
3
7
20
50
101
160
183
243
178
210
Other Receivables
29
37
45
118
68
54
52
63
202
47
Inventory
87
86
105
172
193
207
210
257
303
328
Other Current Assets
6
36
19
33
21
42
36
31
85
133
Total Current Assets
621
698
552
513
699
645
796
867
1 191
921
PP&E Net
196
244
370
427
476
627
693
865
873
1 092
PP&E Gross
196
244
370
427
476
627
693
865
873
1 092
Accumulated Depreciation
58
65
86
109
143
210
263
330
295
190
Intangible Assets
85
111
132
155
160
243
227
250
274
268
Goodwill
0
0
97
97
109
252
251
379
246
274
Note Receivable
0
0
0
49
49
47
46
42
26
149
Long-Term Investments
0
2
118
129
145
126
144
197
256
268
Other Long-Term Assets
27
11
3
3
6
55
87
104
56
109
Other Assets
0
0
97
97
109
252
251
379
246
274
Total Assets
928
N/A
1 067
+15%
1 271
+19%
1 373
+8%
1 643
+20%
1 995
+21%
2 243
+12%
2 704
+21%
2 922
+8%
3 081
+5%
Liabilities
Accounts Payable
13
25
24
43
48
76
86
107
86
114
Accrued Liabilities
5
12
15
15
30
39
71
65
61
45
Short-Term Debt
0
20
71
67
180
295
430
472
310
441
Current Portion of Long-Term Debt
0
0
0
0
0
0
5
24
21
196
Other Current Liabilities
36
37
126
158
212
280
284
587
523
453
Total Current Liabilities
54
94
236
282
470
689
877
1 255
1 000
1 248
Long-Term Debt
0
0
0
0
0
30
25
65
299
174
Deferred Income Tax
0
0
5
4
4
17
17
27
34
35
Minority Interest
34
46
51
53
59
76
114
108
118
131
Other Liabilities
32
41
51
49
56
57
58
53
82
36
Total Liabilities
121
N/A
181
+50%
343
+89%
388
+13%
589
+52%
868
+47%
1 091
+26%
1 508
+38%
1 532
+2%
1 623
+6%
Equity
Common Stock
109
142
433
431
429
435
429
429
439
440
Retained Earnings
302
347
388
443
512
578
591
635
817
850
Additional Paid In Capital
397
397
169
156
140
142
132
132
164
186
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
0
0
0
Treasury Stock
0
0
61
45
27
28
0
0
30
17
Other Equity
0
0
0
0
0
0
0
0
0
0
Total Equity
808
N/A
885
+10%
928
+5%
985
+6%
1 054
+7%
1 127
+7%
1 152
+2%
1 196
+4%
1 390
+16%
1 458
+5%
Total Liabilities & Equity
928
N/A
1 067
+15%
1 271
+19%
1 373
+8%
1 643
+20%
1 995
+21%
2 243
+12%
2 704
+21%
2 922
+8%
3 081
+5%
Shares Outstanding
Common Shares Outstanding
425
425
425
421
418
424
429
429
429
439

See Also

Discover More